Back
Corporate News
Solara Active Pharma Sciences confirms Rs 446.62 crore rights issue proceeds were properly used
16-Oct-2026, 04:38
Solara Active Pharma Sciences Limited announced that there was no deviation or variation in the use of proceeds raised through a rights issue of Rs 446.62 crore in August 2026, according to a regulatory filing on Friday. The company’s audit committee approved a statement confirming the utilization of Rs 334.71 crore for repayment of borrowings and Rs 111.57 crore for general corporate purposes, with the remaining funds held in accounts for future use.
